Clinical studies have demonstrated that patients with HUS have elevated plasma levels of cytokines such as tumor necrosis factor α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6) [13]. The gene discussed is IL6; the disease is hemolytic-uremic syndrome.